Table 3.
Summary of cutoff titer positivity criteria and antibody isotype described in selected studies
Positivity cutoff titer criteria | Antibody target (n studies) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Single titer | Both | Only 4-fold | Range | Total | IgM | IgG | Whole | IgM/IgG | Not stated | Isotype total | |
Country | |||||||||||
American Samoa | 1 | 1 | 1 | 1 | |||||||
Australia | 1 | 1 | 1 | 1 | |||||||
Brazil | 1 | 1 | 2 | 1 | 1 | ||||||
China | 2 | 2 | 1 | 1 | |||||||
Colombia | 1 | 1 | 2 | 1 | 1 | ||||||
Croatia | 1 | 1 | 2 | 1 | 1 | 2 | |||||
Cyprus | 4 | 4 | 2 | 2 | |||||||
Djibouti | 1 | 1 | 1 | 1 | |||||||
France | 3 | 3 | 1 | 1 | 2 | ||||||
Germany | 1 | 1 | 1 | 1 | |||||||
Greece | 5 | 3 | 8 | 1 | 1 | 2 | 1 | 5 | |||
Indonesia | 1 | 3 | 4 | 1 | 1 | 2 | |||||
Israel | 2 | 2 | 1 | 1 | 2 | ||||||
Lao PDR | 1 | 2 | 2 | 5 | 3 | 2 | 5 | ||||
Madagascar | 1 | 1 | 1 | 1 | |||||||
Malaysia | 1 | 1 | 1 | 1 | 2 | ||||||
Malta | 1 | 1 | 1 | 1 | |||||||
Morocco | 1 | 1 | 1 | 1 | |||||||
Nepal | 1 | 1 | 1 | 3 | 1 | 1 | 2 | ||||
New Zealand | 1 | 1 | 1 | 1 | |||||||
Singapore | 1 | 1 | 1 | 1 | |||||||
Spain | 8 | 2 | 1 | 11 | 1 | 4 | 4 | 9 | |||
Sri Lanka | 1 | 3 | 1 | 5 | 1 | 1 | 2 | ||||
Taiwan | 6 | 7 | 13 | 6 | 1 | 7 | |||||
Tanzania | 2 | 1 | 3 | 1 | 1 | 2 | |||||
Thailand | 5 | 5 | 1 | 4 | 5 | ||||||
Tunisia | 6 | 3 | 9 | 2 | 1 | 2 | 1 | 6 | |||
United States | 2 | 4 | 6 | 3 | 1 | 2 | 6 | ||||
Vietnam | 1 | 1 | 1 | 1 | |||||||
Zambia | 2 | 2 | 1 | 1 | |||||||
Total | 57 | 30 | 13 | 2 | 102* | 8 | 16 | 10 | 24 | 17 | 75† |
Study design | |||||||||||
Case series | 21 | 13 | 4 | 1 | 39 | 6 | 3 | 4 | 17 | 9 | 39 |
Cross-sectional studies | 24 | 8 | 1 | 1 | 34 | 3 | 13 | 4 | 6 | 8 | 34 |
Diagnostic accuracy studies | 4 | 1 | 5 | 2 | 2 | 1 | 5 | ||||
Total | 49 | 22 | 5 | 2 | 78 | 9 | 18 | 10 | 24 | 17 | 78 |
Some studies provided different positivity criteria for IgM and IgG.
Three studies were not included as they examined murine typhus in travelers from various countries.